Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Marsha Kay, MD, FAAP, FASGE, FACG, is a native of Cleveland, Ohio. She did her residency in pediatrics and her fellowship in pediatric gastroenterology at Cleveland Clinic, and she has been on staff at Cleveland Clinic since 1993. She is board-certified in Pediatric Gastroenterology with many clinical interests, including Crohn's disease and ulcerative colitis, gastrointestinal endoscopy, foreign bodies and caustic ingestions, celiac disease, GI bleeding, acid peptic disease, and general pediatric gastroenterology.
She has been elected a fellow of the American Society for Gastrointestinal Endoscopy and the American College of Gastroenterology, and she serves on the Executive Council of the Northeastern Ohio Society for Gastrointestinal Endoscopy. She is also a fellow of the American Academy of Pediatrics and a member of the North American Society of Pediatric Gastroenterology and Nutrition. She has served on numerous committees for the North American Society for Pediatric Gastroenterology and Nutrition, the American College of Gastroenterology and the American Society for Gastrointestinal Endoscopy. She is also a media spokesperson for the American Society for Gastrointestinal Endoscopy.
In addition to serving as Department Chair and Director of Pediatric Endoscopy, Dr. Kay also serves as a member of the Fellowship Committee for the Department of Pediatric Gastroenterology and Nutrition at Cleveland Clinic. She has been listed on several occasions in Best Doctors in America, Guide to America's Top Physicians, Guide to America's Pediatricians, and Guide to America's Top Gastroenterologists.
She has lectured at international numerous national and regional scientific meetings in various topics on pediatric gastroenterology with an emphasis on pediatric endoscopy. She has served as the associate editor of Wyllie and Hyams, editors, "Pediatric Gastrointestinal Liver Disease," forth edition, published in 2011, and is primary author and co-author on numerous manuscripts, chapters and review articles.
caustic ingestions, Foreign Body Ingestion, gastroesophageal reflux disease, gastrointestinal endoscopy, inflammatory bowel disease, Pediatric Liver Disease, therapeutic endoscopy, Crohn's Disease, Diagnostic and therapeutic endoscopy, gastroesophageal reflux, Gastrointestinal endoscopy, Inflammatory bowel disease, Innovative use of new technology in the assessment of gastrointestinal tract function in pediatric patients, nutritional assessment and support in children, pediatric gastroenterology, pediatric liver diseases, Peptic Ulcer Disease, peptic ulcer disease, recurrent abdominal pain, small intestine SHORT BOWEL REHAB, Ulcerative Colitis, wireless capsule endoscopy
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 2/13/2014, Dr. Kay has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.